Fate Therapeutics
FATE
#7514
Rank
S$0.36 B
Marketcap
$3.21
Share price
-5.10%
Change (1 day)
10.71%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.99

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.88. In 2022 the company made an earnings per share (EPS) of -$3.86 a decrease over its 2021 EPS that were of -$2.96.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.99-22.42%
2022-$3.8630.49%
2021-$2.967.21%
2020-$2.7645.45%
2019-$1.9019.17%
2018-$1.5917.65%
2017-$1.35-3.77%
2016-$1.41-12.4%
2015-$1.60-3.97%
2014-$1.67-2.09%
2013-$1.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.38 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.36-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.47 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.11 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.60-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA